Correlation Between Protagonist Therapeutics and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Relay Therapeutics, you can compare the effects of market volatilities on Protagonist Therapeutics and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Relay Therapeutics.
Diversification Opportunities for Protagonist Therapeutics and Relay Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Protagonist and Relay is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Relay Therapeutics
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.37 times more return on investment than Relay Therapeutics. However, Protagonist Therapeutics is 2.73 times less risky than Relay Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 4,141 in Protagonist Therapeutics on September 3, 2024 and sell it today you would earn a total of 239.00 from holding Protagonist Therapeutics or generate 5.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Relay Therapeutics
Performance |
| Timeline |
| Protagonist Therapeutics |
| Relay Therapeutics |
Protagonist Therapeutics and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Relay Therapeutics
The main advantage of trading using opposite Protagonist Therapeutics and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |